+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gene Editing Technologies Market by Technology Platform (CRISPR, Meganuclease, TALEN), Application (Agricultural, Industrial, Research Tools), End User, Delivery Method, Disease Indication - Global Forecast 2025-2030- Product Image
Gene Editing Technologies Market by Technology Platform (CRISPR, Meganuclease, TALEN), Application (Agricultural, Industrial, Research Tools), End User, Delivery Method, Disease Indication - Global Forecast 2025-2030- Product Image
Sale

Gene Editing Technologies Market by Technology Platform (CRISPR, Meganuclease, TALEN), Application (Agricultural, Industrial, Research Tools), End User, Delivery Method, Disease Indication - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5924703
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Gene editing technologies are redefining possibilities in life sciences, transforming the way industry leaders approach therapeutics, agriculture, and industrial applications. As the ecosystem matures, adopting advanced tools and collaborative models, organizations need actionable insight to navigate its complexities and secure competitive advantage.

Market Snapshot: Gene Editing Technologies Market

The Gene Editing Technologies Market grew from USD 5.73 billion in 2024 to USD 6.48 billion in 2025. It is expected to continue expanding at a CAGR of 12.72%, reaching USD 11.75 billion by 2030. This expansion reflects ongoing innovation, increased adoption across sectors, and significant strategic investments. Businesses in biopharma, agriculture, and industrial biotechnology are actively seeking new methods to increase efficiency and agility, driving robust market momentum and deeper ecosystem engagement.

Scope & Segmentation: Breadth of Opportunities and Technologies

  • Technology Platform: Includes CRISPR (with base editing, Cas9, and prime editing), meganuclease, TALEN, and ZFN approaches built for various molecular precision requirements and application scopes.
  • Application: Covers agricultural enhancements (crops, livestock), industrial bioprocesses (biofuels, bioplastics), research tools (assays, cell line engineering, library screening), and therapeutic modalities (ex vivo immunotherapies and stem cell therapies, in vivo germline and somatic gene editing).
  • End User: Targets large and small biopharmaceutical companies, contract research organizations (clinical, preclinical), medical centers and hospitals (clinics, hospitals), and research institutes or academic centers (academic, government laboratories).
  • Delivery Method: Incorporates nonviral methods (electroporation, lipid nanoparticle, microinjection) and viral vectors (adeno-associated virus, lentivirus, retrovirus), each suited to different scalability, safety, and clinical parameters.
  • Disease Indication: Encompasses infectious diseases, multiple oncology use cases (hematological malignancies, solid tumors), and rare genetic disorders like cystic fibrosis and sickle cell disease.
  • Regional Coverage: Segmentation spans the Americas (including key U.S. states), Europe, Middle East & Africa (from the EU to leading Middle Eastern and African markets), and Asia-Pacific (targeting major countries and emerging innovation hubs).
  • Company Analysis: Profiles leaders such as Thermo Fisher Scientific, Danaher Corporation, Merck KGaA, Roche Holding AG, Agilent Technologies, Sartorius AG, Bio-Rad Laboratories, QIAGEN N.V., Lonza Group AG, and Takara Bio Inc.

Key Takeaways: Strategic Insights for Decision-Makers

  • Innovative platforms like CRISPR, prime editing, and base editors are propelling rapid advances from research into clinical and agricultural practice, reshaping value chains.
  • Collaborative consortia involving corporate, academic, and governmental stakeholders are driving resource-sharing, particularly in therapeutic development and regulatory strategy.
  • Expansion of local manufacturing and reagent sourcing is emerging as a response to international tariff volatility and to strengthen operational resilience.
  • Digital biology and AI-driven design tools are accelerating the optimization and predictability of editing constructs in both discovery and validation stages.
  • Ethical considerations around human gene editing and emerging regulatory frameworks are influencing strategic investment and stakeholder alignment across key regions.

Tariff Impact: U.S. Measures Reshaping Supply Chains and Cost Structures

Targeted United States tariffs imposed in 2025 on gene editing inputs have shifted supply chain calculations for manufacturers, reagent suppliers, and service organizations. This has triggered increased operational budgets and spurred domestic partnerships for reagent production as well as a broader search for alternative sourcing. Forward-thinking organizations are recalibrating project protocols and investing in localized infrastructure to address long-term efficiency.

Methodology & Data Sources

This report draws on a rigorous, multi-step methodology, merging in-depth secondary research, regulatory analysis, and structured interviews with executive stakeholders. Data was triangulated from scientific literature, patent filings, and authoritative guidelines, while conclusions were validated through peer reviews and quality checks for reliability and currency.

Why This Report Matters

  • Empowers strategic decision-making with a clear breakdown of technology trends, regulatory shifts, and actionable partnership opportunities tailored to senior leaders.
  • Enables efficient risk mitigation and resource allocation by mapping evolving segment implications, supply chain disruptions, and investment priorities across major regions.

Conclusion

Gene editing technologies increasingly underpin progress in healthcare, agriculture, and industrial domains. By combining insight into technology, regulation, and collaboration, this report equips leaders to drive innovation and secure sustainable growth in a dynamic global market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing integration of machine learning algorithms with CRISPR systems to enhance target specificity
5.2. Accelerating commercialization of base editing platforms for single nucleotide correction in genetic therapies
5.3. Expansion of CRISPR-based diagnostics enabling rapid point-of-care detection of infectious diseases
5.4. Development of gene drives for mosquito population control to combat malaria transmission in sub-Saharan Africa
5.5. Emergence of epigenome editing tools for reversible regulation of disease-related gene expression profiles
5.6. Evolving regulatory frameworks for human germline editing influencing research funding and public acceptance
5.7. Collaborations between biotech startups and pharmaceutical companies to advance CAR-T gene editing therapeutics
5.8. Adoption of high-fidelity enCas12a variants to minimize off-target mutations in agricultural genome engineering
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Gene Editing Technologies Market, by Technology Platform
8.1. Introduction
8.2. CRISPR
8.2.1. Base Editing
8.2.1.1. Adenine Base Editing
8.2.1.2. Cytosine Base Editing
8.2.2. Cas9
8.2.3. Prime Editing
8.3. Meganuclease
8.4. TALEN
8.5. ZFN
9. Gene Editing Technologies Market, by Application
9.1. Introduction
9.2. Agricultural
9.2.1. Crops
9.2.2. Livestock
9.3. Industrial
9.3.1. Biofuels
9.3.2. Bioplastics
9.4. Research Tools
9.4.1. Assays
9.4.2. Cell Line Engineering
9.4.3. Library Screening
9.5. Therapeutic
9.5.1. Ex Vivo
9.5.1.1. Immunotherapy
9.5.1.2. Stem Cell Therapy
9.5.2. In Vivo
9.5.2.1. Germline Gene Editing
9.5.2.2. Somatic Gene Editing
10. Gene Editing Technologies Market, by End User
10.1. Introduction
10.2. Biopharmaceutical Companies
10.2.1. Large Biopharma
10.2.2. Small And Medium Biopharma
10.3. Contract Research Organizations
10.3.1. Clinical
10.3.2. Preclinical
10.4. Medical Centers And Hospitals
10.4.1. Clinics
10.4.2. Hospitals
10.5. Research Institutes And Academic Centers
10.5.1. Academic Research
10.5.2. Government Laboratories
11. Gene Editing Technologies Market, by Delivery Method
11.1. Introduction
11.2. Nonviral
11.2.1. Electroporation
11.2.2. Lipid Nanoparticle
11.2.3. Microinjection
11.3. Viral
11.3.1. Adeno Associated Virus
11.3.2. Lentivirus
11.3.3. Retrovirus
12. Gene Editing Technologies Market, by Disease Indication
12.1. Introduction
12.2. Infectious Diseases
12.3. Oncology
12.3.1. Hematological Malignancies
12.3.2. Solid Tumors
12.4. Rare Genetic Disorders
12.4.1. Cystic Fibrosis
12.4.2. Sickle Cell Disease
13. Americas Gene Editing Technologies Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Gene Editing Technologies Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Gene Editing Technologies Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Danaher Corporation
16.3.3. Merck KGaA
16.3.4. Roche Holding AG
16.3.5. Agilent Technologies, Inc.
16.3.6. Sartorius AG
16.3.7. Bio-Rad Laboratories, Inc.
16.3.8. QIAGEN N.V.
16.3.9. Lonza Group AG
16.3.10. Takara Bio Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. GENE EDITING TECHNOLOGIES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GENE EDITING TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. GENE EDITING TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. GENE EDITING TECHNOLOGIES MARKET: RESEARCHAI
FIGURE 26. GENE EDITING TECHNOLOGIES MARKET: RESEARCHSTATISTICS
FIGURE 27. GENE EDITING TECHNOLOGIES MARKET: RESEARCHCONTACTS
FIGURE 28. GENE EDITING TECHNOLOGIES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GENE EDITING TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ADENINE BASE EDITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ADENINE BASE EDITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CYTOSINE BASE EDITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CYTOSINE BASE EDITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CAS9, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CAS9, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY PRIME EDITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY PRIME EDITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEGANUCLEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEGANUCLEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TALEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TALEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ZFN, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ZFN, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CROPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CROPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOFUELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOFUELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPLASTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPLASTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LIBRARY SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LIBRARY SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY GERMLINE GENE EDITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY GERMLINE GENE EDITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SOMATIC GENE EDITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SOMATIC GENE EDITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LARGE BIOPHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LARGE BIOPHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SMALL AND MEDIUM BIOPHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SMALL AND MEDIUM BIOPHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY PRECLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY GOVERNMENT LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY GOVERNMENT LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ELECTROPORATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LIPID NANOPARTICLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LIPID NANOPARTICLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY MICROINJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY MICROINJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ADENO ASSOCIATED VIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ADENO ASSOCIATED VIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LENTIVIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LENTIVIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RETROVIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RETROVIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SICKLE CELL DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SICKLE CELL DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 245. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 246. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 247. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 248. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 249. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 250. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 251. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2024 (USD MILLION)
TABLE 254. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2025-2030 (USD MILLION)
TABLE 255. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2024 (USD MILLION)
TABLE 256. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2025-2030 (USD MILLION)
TABLE 257. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2024 (USD MILLION)
TABLE 258. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2025-2030 (USD MILLION)
TABLE 259. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 260. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 261. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2024 (USD MILLION)
TABLE 262. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2025-2030 (USD MILLION)
TABLE 263. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2024 (USD MILLION)
TABLE 264. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2025-2030 (USD MILLION)
TABLE 265. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 268. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 269. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 270. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 271. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, 2018-2024 (USD MILLION)
TABLE 272. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, 2025-2030 (USD MILLION)
TABLE 273. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, 2018-2024 (USD MILLION)
TABLE 274. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, 2025-2030 (USD MILLION)
TABLE 275. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 276. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 277. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2024 (USD MILLION)
TABLE 278. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2025-2030 (USD MILLION)
TABLE 279. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2024 (USD MILLION)
TABLE 280. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2025-2030 (USD MILLION)
TABLE 281. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 282. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 283. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 284. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 285. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 286. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 287. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 288. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 289. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 290. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 291. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 292. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 293. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2024 (USD MILLION)
TABLE 296. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2025-2030 (USD MILLION)
TABLE 297. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2024 (USD MILLION)
TABLE 298. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2025-2030 (USD MILLION)
TABLE 299. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2024 (USD MILLION)
TABLE 300. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2025-2030 (USD MILLION)
TABLE 301. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 302. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 303. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2024 (USD MILLION)
TABLE 304. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2025-2030 (USD MILLION)
TABLE 305. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2024 (USD MILLION)
TABLE 306. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2025-2030 (USD MILLION)
TABLE 307. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 310. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 311. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 312. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 313. MEXICO GENE EDITING TEC

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Gene Editing Technologies market report include:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Roche Holding AG
  • Agilent Technologies, Inc.
  • Sartorius AG
  • Bio-Rad Laboratories, Inc.
  • QIAGEN N.V.
  • Lonza Group AG
  • Takara Bio Inc.

Table Information

Report AttributeDetails
No. of Pages193
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.48 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.75 Billion
Compound Annual Growth Rate12.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

CRISPR Gene Editing Market by Type (Base Editing, Cas9, Cpf1), Application (Agriculture, Industrial & Energy, Research & Development), End User, Delivery Method - Global Forecast 2025-2030 - Product Image

CRISPR Gene Editing Market by Type (Base Editing, Cas9, Cpf1), Application (Agriculture, Industrial & Energy, Research & Development), End User, Delivery Method - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Cell & Gene Therapy Services Market by Service Type (Analytical Services, Development Services, Manufacturing Services), Technology Platform (Gene Editing, Nonviral Delivery, Viral Vectors), Therapy Type, End User - Global Forecast 2025-2030 - Product Image

Cell & Gene Therapy Services Market by Service Type (Analytical Services, Development Services, Manufacturing Services), Technology Platform (Gene Editing, Nonviral Delivery, Viral Vectors), Therapy Type, End User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
CRISPR-based Gene Editing Market Size, Share and Trends Analysis Report by Product & Service (CRISPR Kits & Reagents), Application (Biomedical, Agricultural), End-use, and Region 2024-2030 - Product Image

CRISPR-based Gene Editing Market Size, Share and Trends Analysis Report by Product & Service (CRISPR Kits & Reagents), Application (Biomedical, Agricultural), End-use, and Region 2024-2030

  • Report
  • 120 Pages
  • Global
From
Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9), Delivery Method (Ex Vivo), Application (Genetic Engineering, Clinical Applications), Mode (Contract, in-house), End Use, Region, with Growth Forecasts, 2025-2030 - Product Image

Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9), Delivery Method (Ex Vivo), Application (Genetic Engineering, Clinical Applications), Mode (Contract, in-house), End Use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Gene Editing - Global Strategic Business Report - Product Image

Gene Editing - Global Strategic Business Report

  • Report
  • 383 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.